Stocks and InvestingStocks and Investing
Thu, November 5, 2020
Wed, November 4, 2020
Tue, November 3, 2020
Mon, November 2, 2020

Eun Yang Downgraded (BPMC) to Hold and Held Target at $96 on, Nov 2nd, 2020


Published on 2024-10-27 14:36:18 - WOPRAI, Eun Yang
  Print publication without navigation


Eun Yang of Jefferies, Downgraded "Blueprint Medicines Corporation" (BPMC) to Hold and Held Target at $96 on, Nov 2nd, 2020.

Eun has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 1 agrees with Eun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Downgraded from Buy to Hold on, Friday, October 30th, 2020


These are the ratings of the 4 analyists that currently disagree with Eun


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020